News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
![Commercial Space Sector Spotlight ① | SpaceX IPO Set to Ignite: Trillion-Dollar Space Investment Opportunity Hits U.S. Stocks [Stock God Contest, $100K Prize Pool]](/news-static/client/media/cover-placeholder.101bcc72032a7c4f0a397f15f3252c92.svg)
TAG experiences 44.9% volatility within 24 hours: Short-term speculation surges as trading volume spikes
Bitget Pulse·2026/04/02 02:47
D（DarOpenNetwork）24-hour volatility at 142.8%: trading volume surges 540%, triggering degen speculation
Bitget Pulse·2026/04/02 02:43
AI agents like OpenClaw could drain crypto wallets via ‘malicious skills’: CertiK
Cointime·2026/04/02 02:37
Q2 Gold Price Outlook: How Long Will the Volatility Continue?
新浪财经·2026/04/02 02:20
ARIA (Aria.AI) fluctuated 41.5% in 24 hours: abnormal surge in trading volume drives sharp price swings
Bitget Pulse·2026/04/02 02:13
DUCK (DuckChain) fluctuated by 40.1% in 24 hours: briefly surged, then retraced after profit-taking
Bitget Pulse·2026/04/02 01:53
Flash
12:38
Cannae Holdings, Inc. has successfully completed the full acquisition of Exeter Rugby Group, significantly advancing the company's strategic shift to focus its investments on sports and entertainment assets.By acquiring full ownership of the rugby club, Cannae Holdings further consolidates its presence in the sector, aiming to identify and integrate high-value entertainment assets. This strategic acquisition not only expands the company's asset portfolio but also positions it more advantageously in the rapidly evolving sports entertainment market.
12:38
Moleculin Biotech, Inc. (Moleculin) recently announced the interim analysis results of its phase 2/3 "Miracle" clinical trial, showing positive data.The results show that the core candidate drug Annamycin demonstrated significantly superior efficacy in inducing complete remission compared to the control group, with the complete remission rate reaching three times that of the control group. This positive data provides strong momentum for the further development of Annamycin in the treatment of acute myeloid leukemia. The success of the interim analysis indicates that the drug has made breakthrough progress in key efficacy indicators, and it is expected to offer new treatment options for patients. The company will continue to advance clinical trials to obtain more confirmatory data.
12:37
U.S. Stock Index Futures Turn Lower On June 30, Dow Jones futures fell by 0.11%, S&P 500 futures declined by 0.07%, and Nasdaq 100 futures decreased by 0.05%.
News